BTG3 and axial length measurement: Of these patients, 12 (40%) only present positivity to lupus anticoagulant (AL), 7 (23.3%) present positivity to AL and antinuclear antibodies (ANA), 6 (20%) present triple positivity to AL, ANA, and antineutrophil cytoplasmic antibodies (ANCA), 3 (10%) were positive to ANA and ANCA, 1 (3.3%) was positive to AL and ANCA, and 1 (3.3%) was positive just to ANA autoantibodies.